204 related articles for article (PubMed ID: 28303004)
1. Serum FABP5 concentration is a potential biomarker for residual risk of atherosclerosis in relation to cholesterol efflux from macrophages.
Furuhashi M; Ogura M; Matsumoto M; Yuda S; Muranaka A; Kawamukai M; Omori A; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Harada-Shiba M; Shimamoto K; Miura T
Sci Rep; 2017 Mar; 7(1):217. PubMed ID: 28303004
[TBL] [Abstract][Full Text] [Related]
2. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
[TBL] [Abstract][Full Text] [Related]
3. Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication.
Furuhashi M; Yuda S; Muranaka A; Kawamukai M; Matsumoto M; Tanaka M; Moniwa N; Ohnishi H; Saitoh S; Shimamoto K; Miura T
Circ J; 2018 Mar; 82(4):1121-1129. PubMed ID: 29445067
[TBL] [Abstract][Full Text] [Related]
4. Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.
Ibarretxe D; Girona J; Amigó N; Plana N; Ferré R; Guaita S; Mallol R; Heras M; Masana L
J Clin Lipidol; 2016; 10(2):330-8.e2. PubMed ID: 27055964
[TBL] [Abstract][Full Text] [Related]
5. Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus.
Furuhashi M; Sakuma I; Morimoto T; Higashiura Y; Sakai A; Matsumoto M; Sakuma M; Shimabukuro M; Nomiyama T; Arasaki O; Node K; Ueda S
Front Endocrinol (Lausanne); 2020; 11():575557. PubMed ID: 33071982
[No Abstract] [Full Text] [Related]
6. Impaired HDL cholesterol efflux capacity in systemic lupus erythematosus patients is related to subclinical carotid atherosclerosis.
Sánchez-Pérez H; Quevedo-Abeledo JC; de Armas-Rillo L; Rua-Figueroa Í; Tejera-Segura B; Armas-González E; Machado JD; García-Dopico JA; Jimenez-Sosa A; Rodríguez-Lozano C; Díaz-González F; González-Gay MA; Ferraz-Amaro I
Rheumatology (Oxford); 2020 Oct; 59(10):2847-2856. PubMed ID: 32065639
[TBL] [Abstract][Full Text] [Related]
7. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
[TBL] [Abstract][Full Text] [Related]
8. HDL cholesterol efflux capacity is inversely associated with subclinical cardiovascular risk markers in young adults: The cardiovascular risk in Young Finns study.
Hunjadi M; Lamina C; Kahler P; Bernscherer T; Viikari J; Lehtimäki T; Kähönen M; Hurme M; Juonala M; Taittonen L; Laitinen T; Jokinen E; Tossavainen P; Hutri-Kähönen N; Raitakari O; Ritsch A
Sci Rep; 2020 Nov; 10(1):19223. PubMed ID: 33154477
[TBL] [Abstract][Full Text] [Related]
9. HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis.
Tejera-Segura B; Macía-Díaz M; Machado JD; de Vera-González A; García-Dopico JA; Olmos JM; Hernández JL; Díaz-González F; González-Gay MA; Ferraz-Amaro I
Arthritis Res Ther; 2017 May; 19(1):113. PubMed ID: 28569219
[TBL] [Abstract][Full Text] [Related]
10. Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis.
Fadaei R; Poustchi H; Meshkani R; Moradi N; Golmohammadi T; Merat S
Sci Rep; 2018 Aug; 8(1):11691. PubMed ID: 30076407
[TBL] [Abstract][Full Text] [Related]
11. Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus.
Bagheri R; Qasim AN; Mehta NN; Terembula K; Kapoor S; Braunstein S; Schutta M; Iqbal N; Lehrke M; Reilly MP
Am J Cardiol; 2010 Oct; 106(8):1118-23. PubMed ID: 20920650
[TBL] [Abstract][Full Text] [Related]
12. FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis.
Tan M; Korkmaz H; Aydın H; Kumbul Doğuç D
Turk J Med Sci; 2019 Oct; 49(5):1490-1497. PubMed ID: 31651119
[TBL] [Abstract][Full Text] [Related]
13. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
Ogura M; Hori M; Harada-Shiba M
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
[TBL] [Abstract][Full Text] [Related]
14. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
[TBL] [Abstract][Full Text] [Related]
15. Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability.
Saksi J; Ijäs P; Mäyränpää MI; Nuotio K; Isoviita PM; Tuimala J; Lehtonen-Smeds E; Kaste M; Jula A; Sinisalo J; Nieminen MS; Lokki ML; Perola M; Havulinna AS; Salomaa V; Kettunen J; Jauhiainen M; Kovanen PT; Lindsberg PJ
Circ Cardiovasc Genet; 2014 Oct; 7(5):588-98. PubMed ID: 25122052
[TBL] [Abstract][Full Text] [Related]
16. High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.
Rohatgi A
Prog Cardiovasc Dis; 2015; 58(1):32-40. PubMed ID: 25968932
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol efflux and reverse cholesterol transport.
Favari E; Chroni A; Tietge UJ; Zanotti I; Escolà-Gil JC; Bernini F
Handb Exp Pharmacol; 2015; 224():181-206. PubMed ID: 25522988
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of fatty acid-binding protein family and metabolic phenotype in the general population.
Ishimura S; Furuhashi M; Watanabe Y; Hoshina K; Fuseya T; Mita T; Okazaki Y; Koyama M; Tanaka M; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Miura T
PLoS One; 2013; 8(11):e81318. PubMed ID: 24278421
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
[TBL] [Abstract][Full Text] [Related]
20. HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients.
Ferraz-Amaro I; Hernández-Hernández MV; Armas-González E; Sánchez-Pérez H; Machado JD; Díaz-González F
Clin Rheumatol; 2020 Jun; 39(6):1871-1880. PubMed ID: 31993889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
